Hakan Akilli

Hakan Akilli

Auto-generated profile, based on publicly available information

Hakan Akilli

Department of Cardiology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2014 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
AAAlpay Aribas
Alpay Aribas
SKSuat Keskin
Suat Keskin
HAHakan Akilli
Hakan Akilli
MKMehmet Kayrak
Mehmet Kayrak
HEHalil Ibrahim Erdogan
Halil Ibrahim Erdogan
TBTaha Tahir Bekci
Taha Tahir Bekci

16 October 2013 in Echocardiography
Verified
Journal Article
Closed access
PDF file
HAHakan Akilli
Hakan Akilli
MKMehmet Kayrak
Mehmet Kayrak
TBTaha Tahir Bekci
Taha Tahir Bekci
HEHalil İbrahim Erdogan
Halil İbrahim Erdogan
AAAlpay Aribas
Alpay Aribas
AUAli Unlu
Ali Unlu

1 August 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
ASAhmet Lütfü Sertdemir
Ahmet Lütfü Sertdemir
AIAbdullah İcLi
Abdullah İcLi
AAAlpay Aribas
Alpay Aribas
STSefa Tatar
Sefa Tatar
NANazire Belgin Akilli
Nazire Belgin Akilli
HAHakan Akilli
Hakan Akilli
Recent studies have linked malnutrition with undesirable outcomes in cardiovascular diseases. However, the underlying mechanism is unknown. Contrast-induced acute kidney injury (CI-AKI) increased cardiovascular mortality after percutaneous coronary intervention (PCI). This study hypothesizes that prognostic nutritional index (PNI) plays a role in the development of CI-AKI in patients with acute coronary syndrome undergoing emergency PCI. This study enrolled 551 patients. PNI was determined as 10× serum albumin (g/dL)+0.005×total lymphocyte count (mm3). CI-AKI was characterized as the increase in serum creatinine ≥0.3 mg/dL level within 48 h after PCI. Patients were classified as either CI-AKI (+) or CI-AKI (-). CI-AKI has occurred in 72 of 551 patients (13.1%). PNI was significantly lower in the CI-AKI (+) group than in the CI-AKI (-) group (44.4±6.6 versus 47.2±5.8, p<0.001, respectively). Multivariate logistic regression analysis showed that PNI [odds ratio, OR: 1.631, 95% confidence interval (CI): 1.168-2.308, p=0.02] and estimated glomerular filtration rate (OR: 3.26, 95%CI 1.733-6.143, p<0.001) were independent risk factors for CI-AKI. PNI is an independent risk factor for CI-AKI. The development of CI-AKI may be the mechanism responsible for the relationship between poor nutritional status and adverse cardiac events.

3 September 2015 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
AIAbdullah Icli
Abdullah Icli
MKMehmet Kayrak
Mehmet Kayrak
HAHakan Akilli
Hakan Akilli
AAAlpay Aribas
Alpay Aribas
MCMükremin⁹ Coskun
Mükremin⁹ Coskun
KOKurtulus Ozdemir
Kurtulus Ozdemir
The aim of this study was to examine the Tpeak-Tend (Tpe/corrected Tpe) interval, which is an indicator of transmural myocardial repolarization, measured non-invasively via electrocardiogram in patients with acute pulmonary embolism (PE), and to investigate the relationship with 30-day mortality and morbidity. The study included 272 patients diagnosed with acute PE, comprising 154 females and 118 males, with a mean age of 63.1 ± 16.8 years. Tpe/cTpe intervals were calculated from the electrocardiograms with a computer program after using a ruler or vernier caliper manual measuring tool to obtain highly sensitive measurements. The relationship between the electrocardiogram values and 30-days mortality and morbidity were measured. The study group was divided into three groups according to cTpe intervals: Group 1, < 113 ms; Group 2, 113–133 ms; and Group 3, > 133 ms. White blood cell count and troponin T levels, corrected QT intervals with QRS complex durations, percentage of right ventricle dilatation with right/left-ventricular ratio, 30-day death, and combinations of these values were seen at a higher rate in Group 3 patients compared to the other groups. Kaplan–Meier analysis showed that the cTpe interval measured at > 126 ms could be used as a cut-off value in the prediction of mortality and morbidity. The cTpe cut-off values of 126 ms had sensivity, specificity, negative predictive value, and positive predictive value of 80.56 %, 59.32 %, 95.2 %, and 23.2 %, respectively. cTpe interval could be a useful method in early risk stratification in patients with acute PE.

1 December 2012 in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
AAAlpay Aribas
Alpay Aribas
HAHakan Akilli
Hakan Akilli
EGEnes Elvin Gul
Enes Elvin Gul
MKMehmet Kayrak
Mehmet Kayrak
KDKenan Demir
Kenan Demir
HGHasan Gok
Hasan Gok
High neutrophil/lymphocyte ratio (NLR) has been associated with post-operative AF development in patients who underwent cardiac surgery. In this study, effectiveness of NLR for prediction of recurrence after electrical cardioversion (CV) in non-valvular AF was investigated. A total of 149 patients who underwent a successful CV were included in this prospective cohort study. Baseline complete blood cell count, routine biochemical tests, high sensitive C-reactive protein (hs-CRP), and echocardiographic measurements were examined. After CV, patients were monitored over six months for recurrence. Baseline characteristics of recurrence group were compared with sinus rhythm group by using Student`s t -test. Logistic regression analysis was used to determine predictors of recurrence. Recurrence occurred in a total of 46 patients (30.9%). Median AF duration [16 (IQR:14.25) vs. 12 (IQR:11) months, p=0.01], baseline hs-CRP [9.80 (IQR: 8.50) mg/dL vs. 4.28 (IQR: 5.65) mg/dL, p=0.002] and left atrium (LA) diameter (4.5±0.4 cm, 4.3±0.5 cm, p=0.023) were significantly higher in the recurrence group than sinus rhythm group. Median NLR was comparable in recurrence and sinus groups [2.38 (IQR: 2.09) vs. 2.23, (IQR: 1.23) p=0.96, respectively]. There was a weak correlation between NLR and hs-CRP (r=0.22, p=0.05) and age (r=0.24, p=0.02). In multiple logistic regression analysis, hs-CRP [OR: 1.34 (1.09-1.65 95% CI) p=0.006], LA diameter [OR: 11.92 (1.84-77.07 95% CI) p=0.01], spontaneous echo contrast positivity, [OR: 5.40 (1.04-12.02 95% CI) p=0.045] and systolic blood pressure [OR: 1.05 (1.01-1.10 95% CI) p=0.03] were independent predictors of AF recurrence. NLR failed to predict AF recurrence after a successful electrical CV, but hs-CRP remained an inflammatory marker of AF recurrence.

1 July 2016 in American Journal of Therapeutics
Verified
Journal Article
Closed access
GAGokhan Altunbas
Gokhan Altunbas
MYMehmet Yazıcı
Mehmet Yazıcı
YSYalcin Solak
Yalcin Solak
EGEnes E. Gul
Enes E. Gul
MKMehmet Kayrak
Mehmet Kayrak
KOKurtulus Ozdemir
Kurtulus Ozdemir
It is of clinical importance to determine creatinine clearance and adjust doses of prescribed drugs accordingly in patients with heart failure to prevent untoward effects. There is a scarcity of studies in the literature investigating this issue particularly in patients with heart failure, in whom many have impaired kidney function. The purpose of this study was to determine the degree of awareness of medication prescription as to creatinine clearance in patients hospitalized with heart failure. Patients hospitalized with a diagnosis of heart failure were retrospectively evaluated. Among screened charts, patients with left ventricular ejection fraction <40% and an estimated glomerular filtration rate (eGFR) of ≤50 mL/min were included in the analysis. The medications and respective doses prescribed at discharge were recorded. Medications requiring renal dose adjustment were determined and evaluated for appropriate dosing according to eGFR. A total of 388 patients with concomitant heart failure and renal dysfunction were included in the study. The total number of prescribed medications was 2808 and 48.3% (1357 medications) required renal dose adjustment. Of the 1357 medications, 12.6% (171 medications) were found to be inappropriately prescribed according to eGFR. The most common inappropriately prescribed medications were famotidine, metformin, perindopril, and ramipril. A significant portion of medications used in heart failure requires dose adjustment. Our results showed that in a typical cohort of patients with heart failure, many drugs are prescribed at inappropriately high doses according to creatinine clearance. Awareness should be increased among physicians caring for patients with heart failure to prevent adverse events related to medications.